Nxera Pharma Co., Ltd. / Financial strength (Piotroski F-Value)

    The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.

    Financial strength (Piotroski F-Value)
    5 / 9
    Return on assets (ROA) greater than 0
    close -2.3%
    Operating cash flow greater than 0
    close -$50.81M
    ROA greater than previous year
    check -2.3% > -6.3%
    Cash flow return on assets (CFROA) greater than Return on assets (ROA)
    close -6.1% ≤ -2.3%
    Leverage ratio lower than previous year
    check 40.1% < 41.2%
    Current ratio greater than previous year
    close 361.7% ≤ 410.5%
    No new common stock issued last year
    check $0.00
    Gross margin greater than previous year
    check 72.5% > 64.2%
    Asset turnover greater than previous year
    check 21.6% > 14.9%

    F-Value history

    The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.

    5
    4
    5
    4
    2
    1
    1
    6
    6
    5
    4
    5
    5
    5
    5
    4
    3
    3
    4
    5
    5
    7
    8
    7
    8
    3
    3
    5
    3
    3
    3
    2
    2
    5
    6
    6
    3
    5
    6
    6
    4
    5
    5
    6
    7
    6
    8
    7
    3
    1
    1
    2
    5
    4
    4
    5

    Notifications